These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors. Koppel I; Timmusk T Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat. Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060 [TBL] [Abstract][Full Text] [Related]
7. Increasing progranulin levels and blockade of the ERK1/2 pathway: upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia. Alquezar C; Esteras N; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á Eur Neuropsychopharmacol; 2015 Mar; 25(3):386-403. PubMed ID: 25624003 [TBL] [Abstract][Full Text] [Related]
9. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients. Valdez C; Wong YC; Schwake M; Bu G; Wszolek ZK; Krainc D Hum Mol Genet; 2017 Dec; 26(24):4861-4872. PubMed ID: 29036611 [TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase as a new target for cancer chemotherapy. Yoshida M; Furumai R; Nishiyama M; Komatsu Y; Nishino N; Horinouchi S Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S20-6. PubMed ID: 11587361 [TBL] [Abstract][Full Text] [Related]
11. Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases. Chou CJ; Herman D; Gottesfeld JM J Biol Chem; 2008 Dec; 283(51):35402-9. PubMed ID: 18953021 [TBL] [Abstract][Full Text] [Related]
12. Comparison of three zinc binding groups for HDAC inhibitors - A potency, selectivity and enzymatic kinetics study. Yue K; Qin M; Huang C; James Chou C; Jiang Y; Li X Bioorg Med Chem Lett; 2022 Aug; 70():128797. PubMed ID: 35580726 [TBL] [Abstract][Full Text] [Related]
13. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial. Ljubenkov PA; Edwards L; Iaccarino L; La Joie R; Rojas JC; Koestler M; Harris B; Boeve BF; Borroni B; van Swieten JC; Grossman M; Pasquier F; Frisoni GB; Mummery CJ; Vandenberghe R; Le Ber I; Hannequin D; McGinnis SM; Auriacombe S; Onofrj M; Goodman IJ; Riordan HJ; Wisniewski G; Hesterman J; Marek K; Haynes BA; Patzke H; Koenig G; Hilt D; Moebius H; Boxer AL JAMA Netw Open; 2021 Sep; 4(9):e2125584. PubMed ID: 34559230 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia. Rosenthal ZC; Fass DM; Payne NC; She A; Patnaik D; Hennig KM; Tesla R; Werthmann GC; Guhl C; Reis SA; Wang X; Chen Y; Placzek M; Williams NS; Hooker J; Herz J; Mazitschek R; Haggarty SJ Sci Rep; 2024 Apr; 14(1):9064. PubMed ID: 38643236 [TBL] [Abstract][Full Text] [Related]
15. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Furumai R; Komatsu Y; Nishino N; Khochbin S; Yoshida M; Horinouchi S Proc Natl Acad Sci U S A; 2001 Jan; 98(1):87-92. PubMed ID: 11134513 [TBL] [Abstract][Full Text] [Related]
16. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Khan N; Jeffers M; Kumar S; Hackett C; Boldog F; Khramtsov N; Qian X; Mills E; Berghs SC; Carey N; Finn PW; Collins LS; Tumber A; Ritchie JW; Jensen PB; Lichenstein HS; Sehested M Biochem J; 2008 Jan; 409(2):581-9. PubMed ID: 17868033 [TBL] [Abstract][Full Text] [Related]
17. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers. Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524 [TBL] [Abstract][Full Text] [Related]
19. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases. Cleophas MC; Crişan TO; Lemmers H; Toenhake-Dijkstra H; Fossati G; Jansen TL; Dinarello CA; Netea MG; Joosten LA Ann Rheum Dis; 2016 Mar; 75(3):593-600. PubMed ID: 25589513 [TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of panobinostat, a novel histone deacetylase (HDAC) inhibitor: review and perspectives. Srinivas NR Xenobiotica; 2017 Apr; 47(4):354-368. PubMed ID: 27226420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]